Literature DB >> 16650537

Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection.

Kenichiro Watanabe1, Shinichi Ogata, Seiji Kawazoe, Kazuyo Watanabe, Takanori Koyama, Tetsuro Kajiwara, Yuichiro Shimoda, Yukari Takase, Kouji Irie, Masanobu Mizuguchi, Seiji Tsunada, Ryuichi Iwakiri, Kazuma Fujimoto.   

Abstract

BACKGROUND: EMR is currently a standard treatment for mucosal gastric tumors. Endoscopic submucosal dissection (ESD) has been developed for en bloc resection.
OBJECTIVE: We evaluated the clinical outcomes of ESD compared with conventional EMR.
DESIGN: Not applicable.
SETTING: A historical control study was performed between EMR and ESD. PATIENTS: EMR of 245 gastric tumors was performed in 229 patients. Lesions were divided into two groups. Conventional EMR was performed in group A from February 1999 to June 2001, and ESD was performed in group B from July 2001 to March 2004. Group B was divided into subgroups: subgroup B-1 underwent ESD from July 2001 to March 2003 and subgroup B-2 from April 2003 to March 2004.
INTERVENTIONS: All lesions were resected with conventional EMR or with ESD. MAIN OUTCOME MEASUREMENTS: En bloc resection rate, rate in completeness of resection, required time, remnant ratio, and complications were evaluated.
RESULTS: With regard to lesions >10 mm in size, the en bloc resection rate and the rate in completeness of resection of group B was significantly higher than that of group A (p < 0.01). Although the required time was longer in group B than A (p < 0.01), it was shorter in subgroup B-2 compared with B-1 (p < 0.05) with lesions < or =10 mm in size. The remnant ratio and perforation rate were not different between groups. LIMITATIONS: Not applicable.
CONCLUSIONS: The en bloc resection rate was better with ESD than with conventional EMR. The required time was longer in ESD, but this disadvantage might be improved with experience.

Entities:  

Mesh:

Year:  2006        PMID: 16650537     DOI: 10.1016/j.gie.2005.08.049

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  86 in total

1.  Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection.

Authors:  Yosuke Muraki; Shotaro Enomoto; Mikitaka Iguchi; Mitsuhiro Fujishiro; Naohisa Yahagi; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

Review 2.  Endoscopic submucosal dissection--current success and future directions.

Authors:  Hironori Yamamoto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

3.  Predictive factors for local recurrence after endoscopic resection for early gastric cancer: long-term clinical outcome in a single-center experience.

Authors:  Jun Chul Park; Sang Kil Lee; Ju Hee Seo; Yu Jin Kim; Hyunsoo Chung; Sung Kwan Shin; Yong Chan Lee
Journal:  Surg Endosc       Date:  2010-04-29       Impact factor: 4.584

4.  Efficacy and safety of endoscopic submucosal dissection for early gastric cancer in patients with comorbid diseases.

Authors:  Beom Jin Kim; Tae Hoon Chang; Jae J Kim; Byung-Hoon Min; Jun Haeng Lee; Hee Jung Son; Poong-Lyul Rhee; Jong Chul Rhee; Kyung Mee Kim; Chul Keun Park
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

5.  Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosis.

Authors:  Young Lan Kwon; Eun Soo Kim; Kyung In Lee; Yong Jin Kim; Chang Wook Park; Yun Jung Kim; Hye Jin Seo; Kwang Bum Cho; Kyung Sik Park; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang
Journal:  Surg Endosc       Date:  2010-12-07       Impact factor: 4.584

6.  Feasibility of full-thickness gastric resection using master and slave transluminal endoscopic robot and closure by Overstitch: a preclinical study.

Authors:  Philip W Y Chiu; S J Phee; Z Wang; Z Sun; Carmen C Poon; T Yamamoto; I Penny; Jennie Y Y Wong; James Y W Lau; K Y Ho
Journal:  Surg Endosc       Date:  2013-08-29       Impact factor: 4.584

7.  Comparison of clinical outcomes among different endoscopic resection methods for treating colorectal neoplasia.

Authors:  Yun Jung Kim; Eun Soo Kim; Kwang Bum Cho; Kyung Sik Park; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang
Journal:  Dig Dis Sci       Date:  2013-02-06       Impact factor: 3.199

8.  Predictive factors of endoscopic submucosal dissection procedure time for gastric superficial neoplasia.

Authors:  Zhong-Sheng Lu; Yun-Sheng Yang; Dan Feng; Shu-Fang Wang; Jing Yuan; Jin Huang; Xiang-Dong Wang; Jiang-Yun Meng; Hong Du; Hong-Bin Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 9.  Perspective on the practical indications of endoscopic submucosal dissection of gastrointestinal neoplasms.

Authors:  Mitsuhiro Fujishiro
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

10.  Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study.

Authors:  Tomohiro Kato; Hiroshi Araki; Fumito Onogi; Takashi Ibuka; Akihiko Sugiyama; Eiichi Tomita; Masahito Nagaki; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.